{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:14:37Z","timestamp":1793646877244,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Theramex"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Among Australians aged 50 and over, an estimated 1 in 4 men and 2 in 5 women will experience a minimal trauma fracture during their remaining lifetime. Effective fracture prevention is hindered by substantial undertreatment, even of patients who clearly warrant pharmacological therapy. Poor adherence to osteoporosis treatment is also a leading cause of repeat fractures and hospitalisation. The aim of this study was to identify current osteoporosis treatment patterns and gaps in practice in Australia, using general practice data, and to explore general practitioners\u2019 (GPs\u2019) attitudes to osteoporosis treatment and their views on patient factors affecting osteoporosis management.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The study was conducted in two phases. Phase 1 was a longitudinal retrospective cohort study which utilised data from MedicineInsight \u2013 a national general practice data program that extracts longitudinal, de-identified patient data from clinical information systems (CISs) of participating general practices. Phase 2 included semi-structured, in-depth telephone interviews with a sample of MedicineInsight practice GPs. Data were analysed using an inductive thematic analysis method informed by the theory of planned behaviour.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A diagnosis of osteoporosis was recorded in 12.4% of patients over the age of 50\u2009years seen in general practice. Of those diagnosed with osteoporosis, almost a quarter were not prescribed osteoporosis medicines. From 2012 to 17, there was a progressive increase in the number of denosumab prescriptions, while prescriptions for bisphosphonates and other osteoporosis medicines decreased. More than 80% of patients who ceased denosumab treatment had no subsequent bisphosphonate prescription recorded. Interviews with GPs revealed beliefs and attitudes that may have influenced their intentions towards prescribing and osteoporosis management.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study suggests that within the Australian general practice setting, osteoporosis is underdiagnosed and undertreated. In addition, it appears that most patients who ceased denosumab treatment had no record of subsequent antiresorptive therapy, which would place them at risk of further fractures. The study supports the need for the development of clinical education programs addressing GP knowledge gaps and attitudes, and the implementation of specific interventions such as good reminder\/recall systems to avoid delays in reviewing and treating patients with osteoporosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12875-020-01103-2","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T11:03:27Z","timestamp":1581505407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8949-5051","authenticated-orcid":false,"given":"Pradnya","family":"Naik-Panvelkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Elgebaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Thistlethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"1103_CR1","unstructured":"Endocrinology Expert Group: Therapeutic Guidelines: Endocrinology: version 5. In. Melbourne, VIC: Therapeutic Guidelines Ltd; 2014."},{"issue":"11","key":"1103_CR2","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.1968","volume":"28","author":"D Bliuc","year":"2013","unstructured":"Bliuc D, Nguyen ND, Nguyen TV, Eisman JA, Center JR. Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res. 2013;28(11):2317\u201324.","journal-title":"J Bone Miner Res"},{"key":"1103_CR3","unstructured":"Australian Institute of Health and Welfare: Estimating the prevalence of osteoporosis. In. Canberra, ACT: AIHW; 2014."},{"key":"1103_CR4","volume-title":"Osteoporosis costing all Australians a new burden of disease analysis \u2013 2012 to 2022. In","author":"JJ Watts","year":"2017","unstructured":"Watts JJ, Abimanyi-Ochom J, Sanders KM. Osteoporosis costing all Australians a new burden of disease analysis \u2013 2012 to 2022. In. Osteoporosis Australia: Glebe, NSW; 2017."},{"key":"1103_CR5","first-page":"CD001155","volume":"1","author":"GA Wells","year":"2008","unstructured":"Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008;1:CD001155.","journal-title":"Cochrane Database Syst Rev"},{"key":"1103_CR6","unstructured":"Royal Australian College of General Practitioners: Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age. In., Second edition edn. Melbourne, VIC: RACGP; 2017."},{"key":"1103_CR7","unstructured":"Pharmaceutical Benefits Scheme [http:\/\/www.pbs.gov.au\/pbs\/home ] Accessed 8 November 2019."},{"key":"1103_CR8","unstructured":"Australian Institute of Health and Welfare: Use of antiresorptive agents for osteoporosis management. In. Canberra: Australian Institute of Health and Welfare; 2011: 42."},{"issue":"1","key":"1103_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/jbm4.10046","volume":"3","author":"G Major","year":"2019","unstructured":"Major G, Ling R, Searles A, Niddrie F, Kelly A, Holliday E, Attia J, Bogduk N. The costs of confronting osteoporosis: cost study of an Australian fracture liaison service. JBMR Plus. 2019;3(1):56\u201363.","journal-title":"JBMR Plus"},{"issue":"3","key":"1103_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jbmr.3074","volume":"32","author":"S Khosla","year":"2017","unstructured":"Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, Shane E. Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res. 2017;32(3):424\u201330.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1103_CR11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","volume":"5","author":"S Khosla","year":"2017","unstructured":"Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5(11):898\u2013907.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1103_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.5694\/mja11.11201","volume":"195","author":"MJ Seibel","year":"2011","unstructured":"Seibel MJ. No more excuses: fracture liaison services work and are cost-effective. Med J Aust. 2011;195(10):566\u20137.","journal-title":"Med J Aust"},{"key":"1103_CR13","unstructured":"Australian Bureau of Statistics: 4364.0.55.002 - Health Service Usage and Health Related Actions, Australia, 2014\u201315. In. Canberra, ACT: ABS; 2017."},{"issue":"11","key":"1103_CR14","first-page":"814","volume":"45","author":"CA Inderjeeth","year":"2016","unstructured":"Inderjeeth CA, Inderjeeth AJ, Raymond WD. Medication selection and patient compliance in the clinical management of osteoporosis. Aust Fam Physician. 2016;45(11):814\u20137.","journal-title":"Aust Fam Physician"},{"key":"1103_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11657-016-0272-5","volume":"11","author":"BR Lindsay","year":"2016","unstructured":"Lindsay BR, Olufade T, Bauer J, Babrowicz J, Hahn R. Patient-reported barriers to osteoporosis therapy. Arch Osteoporos. 2016;11:19.","journal-title":"Arch Osteoporos"},{"issue":"3","key":"1103_CR16","first-page":"135","volume":"35","author":"P Sambrook","year":"2006","unstructured":"Sambrook P. Compliance with treatment in osteoporosis patients--an ongoing problem. Aust Fam Physician. 2006;35(3):135\u20137.","journal-title":"Aust Fam Physician"},{"issue":"6","key":"1103_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/jbmr.3110","volume":"32","author":"AD Anastasilakis","year":"2017","unstructured":"Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O. Clinical features of 24 patients with rebound-associated vertebral fractures after Denosumab discontinuation: systematic review and additional cases. J Bone Miner Res. 2017;32(6):1291\u20136.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1103_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11914-019-00502-4","volume":"17","author":"O Lamy","year":"2019","unstructured":"Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG. Stopping Denosumab. Curr Osteoporos Rep. 2019;17(1):8\u201315.","journal-title":"Curr Osteoporos Rep"},{"key":"1103_CR19","unstructured":"NPS MedicineWise: General practice insights report July 2016\u2013June 2017: a working paper. In. Sydney, NSW: NPS MedicineWise; 2018."},{"key":"1103_CR20","unstructured":"NPS MedicineWise: MedicineInsight data book version 2.1. In. Sydney, NSW: NPS MedicineWise; October 2018."},{"key":"1103_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychology. 2006;3:77\u2013101.","journal-title":"Qual Res Psychology"},{"issue":"2","key":"1103_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","volume":"50","author":"I Ajzen","year":"1991","unstructured":"Ajzen I. The theory of planned behaviour. Organ Behav Hum Decis Process. 1991;50(2):179\u2013211.","journal-title":"Organ Behav Hum Decis Process"},{"issue":"2","key":"1103_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jcpt.12037","volume":"38","author":"V Tsiantou","year":"2013","unstructured":"Tsiantou V, Shea S, Martinez L, Agius D, Basak O, Faresjo T, Moschandreas J, Samoutis G, Symvoulakis EK, Lionis C. Eliciting general practitioners' salient beliefs towards prescribing: a qualitative study based on the theory of planned behaviour in Greece. J Clin Pharm Ther. 2013;38(2):109\u201314.","journal-title":"J Clin Pharm Ther"},{"key":"1103_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/PPA.S78628","volume":"9","author":"L Guenette","year":"2015","unstructured":"Guenette L, Lauzier S, Guillaumie L, Giguere G, Gregoire JP, Moisan J. Patients' beliefs about adherence to oral antidiabetic treatment: a qualitative study. Patient Prefer Adherence. 2015;9:413\u201320.","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"1103_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5694\/mja11.10571","volume":"195","author":"MJ Henry","year":"2011","unstructured":"Henry MJ, Pasco JA, Nicholson GC, Kotowicz MA. Prevalence of osteoporosis in Australian men and women: Geelong osteoporosis study. Med J Aust. 2011;195(6):321\u20132.","journal-title":"Med J Aust"},{"issue":"7","key":"1103_CR26","first-page":"508","volume":"46","author":"M Elliott-Rudder","year":"2017","unstructured":"Elliott-Rudder M, Harding C, McGirr J, Seal A, Pilotto L. Using electronic medical records to assess the rate of treatment for osteoporosis in Australia. Aust Fam Physician. 2017;46(7):508\u201312.","journal-title":"Aust Fam Physician"},{"issue":"6","key":"1103_CR27","doi-asserted-by":"publisher","first-page":"e0158365","DOI":"10.1371\/journal.pone.0158365","volume":"11","author":"S Alami","year":"2016","unstructured":"Alami S, Hervouet L, Poiraudeau S, Briot K, Roux C. Barriers to effective postmenopausal osteoporosis treatment: a qualitative study of Patients' and Practitioners' views. PLoS One. 2016;11(6):e0158365.","journal-title":"PLoS One"},{"issue":"6","key":"1103_CR28","first-page":"423","volume":"42","author":"D Parker","year":"2013","unstructured":"Parker D. An audit of osteoporotic patients in an Australian general practice. Aust Fam Physician. 2013;42(6):423\u20137.","journal-title":"Aust Fam Physician"},{"issue":"12","key":"1103_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1359\/jbmr.040905","volume":"19","author":"J Eisman","year":"2004","unstructured":"Eisman J, Clapham S, Kehoe L. Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare study. J Bone Miner Res. 2004;19(12):1969\u201375.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1103_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00198-008-0686-z","volume":"20","author":"JS Chen","year":"2009","unstructured":"Chen JS, Hogan C, Lyubomirsky G, Sambrook PN. Management of osteoporosis in primary care in Australia. Osteoporos Int. 2009;20(3):491\u20136.","journal-title":"Osteoporos Int"},{"issue":"10","key":"1103_CR31","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s00198-017-4131-z","volume":"28","author":"AS Mendis","year":"2017","unstructured":"Mendis AS, Ganda K, Seibel MJ. Barriers to secondary fracture prevention in primary care. Osteoporos Int. 2017;28(10):2913\u20139.","journal-title":"Osteoporos Int"},{"issue":"10","key":"1103_CR32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/1060028018768808","volume":"52","author":"P Morizio","year":"2018","unstructured":"Morizio P, Burkhart JI, Ozawa S. Denosumab: a unique perspective on adherence and cost-effectiveness compared with Oral bisphosphonates in osteoporosis patients. Ann Pharmacother. 2018;52(10):1031\u201341.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1103_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","volume":"23","author":"N Freemantle","year":"2012","unstructured":"Freemantle N, Satram-Hoang S, Tang ET, Kaur P, Macarios D, Siddhanti S, Borenstein J, Kendler DL. Final results of the DAPS (Denosumab adherence preference satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int. 2012;23(1):317\u201326.","journal-title":"Osteoporos Int"},{"key":"1103_CR34","unstructured":"Australian Medicines Handbook. Adelaide, SA: AMH Pty Ltd; 2018."},{"issue":"2","key":"1103_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M, Roux C, Torring O, Valter I, Wang AT, et al. Vertebral fractures after discontinuation of Denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. 2018;33(2):190\u20138.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1103_CR36","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00198-017-3919-1","volume":"28","author":"MR McClung","year":"2017","unstructured":"McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki EM. Observations following discontinuation of long-term denosumab therapy. Osteoporos Int. 2017;28(5):1723\u201332.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1103_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.18773\/austprescr.2017.050","volume":"40","author":"T Usherwood","year":"2017","unstructured":"Usherwood T. Encouraging adherence to long-term medication. Aust Prescr. 2017;40(4):147\u201350.","journal-title":"Aust Prescr"},{"issue":"1\u20132","key":"1103_CR38","first-page":"78","volume":"37","author":"L Tobin","year":"2008","unstructured":"Tobin L, de Almedia Neto AC, Wutzke S, Patterson C, Mackson J, Weekes L, Williamson M. Influences on the prescribing of new drugs. Aust Fam Physician. 2008;37(1\u20132):78\u201380 3.","journal-title":"Aust Fam Physician"},{"key":"1103_CR39","unstructured":"My Health Record [https:\/\/www.myhealthrecord.gov.au\/] Accessed 8 November 2019."}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-020-01103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12875-020-01103-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-020-01103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T12:20:06Z","timestamp":1613046006000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-020-01103-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1186\/s12875-020-01103-2","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The RACGP National Research and Evaluation Ethics Committee granted ethics approval for the MedicineInsight program (NREEC 17\u2013017) in December 2017 for standard operations and uses of the MedicineInsight database including the ongoing collection of de-identified data.The qualitative GP study received ethics approval from Bellberry Human Research Ethics Committee (HREC 2018\u201307-533). Written informed consent was obtained from participating GPs prior to conducting the interviews.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}